2015
DOI: 10.4103/1008-682x.146973
|View full text |Cite
|
Sign up to set email alerts
|

Chronic administration of sildenafil improves erectile function in a rat model of chronic renal failure

Abstract: The relationship between erectile dysfunction (ED) and chronic renal failure (CRF) has been reported in several studies. This study aimed to investigate whether the chronic use of sildenafil could enhance the erectile capacity in CRF-induced rats. In addition, we assessed the effect of that treatment on certain molecules, which have been suggested to play crucial roles in erectile physiology and CRF-related ED as well. Three groups of animals were utilized: (1) age-matched control rats, (2) CRF-induced rats, (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 25 publications
(41 reference statements)
0
7
0
Order By: Relevance
“…The side effects of sildenafil citrate are mostly mild to moderate. But, with higher doses and long term administration of the sildenafil citrate the side effect become severe [19] .…”
Section: Discussionmentioning
confidence: 99%
“…The side effects of sildenafil citrate are mostly mild to moderate. But, with higher doses and long term administration of the sildenafil citrate the side effect become severe [19] .…”
Section: Discussionmentioning
confidence: 99%
“…PDE‐5 inhibitors increase the concentration of cyclic GMP in the corpus cavernosum smooth muscle, relax the smooth muscle, and affect erectile function. 5 , 80 , 81 , 82 , 83 Although PDE‐5 inhibitors have been shown to be effective against several types of ED, there are cases in which it is ineffective against ED associated with diabetes mellitus or neuropathy after radical prostatectomy. 4 , 5 The effect of chronic administration of PDE‐5 inhibitors as a treatment for refractory ED was investigated.…”
Section: Development Of Medical Technology and Application To ...mentioning
confidence: 99%
“…The first‐line drug used for ED treatment is a PDE‐5 inhibitor. PDE‐5 inhibitors increase the concentration of cyclic GMP in the corpus cavernosum smooth muscle, relax the smooth muscle, and affect erectile function 5,80–83 . Although PDE‐5 inhibitors have been shown to be effective against several types of ED, there are cases in which it is ineffective against ED associated with diabetes mellitus or neuropathy after radical prostatectomy 4,5 .…”
Section: Development Of Medical Technology and Application To Ed Trea...mentioning
confidence: 99%
“…), one hour prior glycerol injection. All drug doses are selected according to previous reports (Gurbuz, Kol et al 2015). All rats were deprived from water with free access to food for 24 hrs and kept in metabolic cages for collection of urine.…”
Section: Rhabdomyolysis-induced Aki Rat Model and Experimental Designmentioning
confidence: 99%